Clinical Trial Update: Intestinal Remodeling And Reprogramming of Glucose Metabolism Following Laparoscopic Roux-en-Y Gastric Bypass [NA]

View source ↗

Summary

A Duke University-sponsored trial investigating intestinal remodeling and glucose metabolism after Roux-en-Y gastric bypass has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Duke University | Conditions: Type 2 Diabetes, Obesity | NA | Status: WITHDRAWN